Mounjy – GLP-1 Medication Tracker

A private, focused app for people using GLP-1 medications (Ozempic, Mounjaro, etc.) to log shots, weight, side effects, and progress without sharing data with third-party services. Users get medication reminders, Apple Health integration, and a simple interface designed specifically for this use case.

GLP-1 prescriptions have exploded — semaglutide and tirzepatide are among the fastest-growing drug categories in the US, with millions of new patients entering a weekly injection routine that genuinely benefits from structured tracking. MyFitnessPal and general health apps handle this poorly because they're built around diet logging, not injection schedules, side-effect patterns, and dose escalation timelines; no clear incumbent owns this specific niche. The $2k–$10k/mo revenue band is realistic via a low-friction subscription (say $4–7/mo) given the audience size and the fact that people actively spending $800–$1,200/mo on medication will pay a few dollars for a tool that helps them use it correctly. The biggest risk is that GLP-1 patients cluster heavily in the 40–65 demographic, which tends toward lower app-store conversion and higher churn, and if the major pharmacy apps (CVS, Amazon Pharmacy) or device makers add this natively, the addressable market shrinks fast.